MASS
908 Devices Inc.
$8.17
+1.11%
2026-05-08
About 908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Key Fundamentals
Forward P/E
-25.66
EPS (TTM)
$-0.97
ROE
-24.1%
Revenue Growth (YoY)
13.6%
Profit Margin
-62.4%
Debt/Equity
3.33
Price/Book
2.03
Beta
0.49
Market Cap
$303.3M
Avg Volume (10D)
315K
Recent Breakout Signals
No recent breakout signals detected for MASS.
Recent Price Range (60 Days)
60D High
$8.22
60D Low
$5.70
Avg Volume
270K
Latest Close
$8.17
Get breakout alerts for MASS
Sign up for Breakout Scanner to receive daily notifications when MASS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
908 Devices Inc. (MASS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors MASS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. MASS operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.